The largest database of trusted experimental protocols

Prism 9 program

Manufactured by GraphPad
Sourced in United States

GraphPad Prism 9 is a data analysis and graphing software program. It provides tools for data organization, statistical analysis, and visualization. The program offers a user-friendly interface to help researchers and scientists analyze their data effectively.

Automatically generated - may contain errors

5 protocols using prism 9 program

1

Adherence to Endocrine Therapy in Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
No power analysis was performed since we included all patients operated for BC during 2015 to 2016 in Region Halland. The χ2-test was used to compare categorical variables between groups. The Mann-Whitney test was used to compare continuous variables. Bivariate logistic regression analysis was performed and crude odds ratios and adjusted odds ratios were calculated for explanatory variables correlating with the dichotomous dependent variable adherence (adherent vs non-adherent). Adherence to ET over time was depicted with the Kaplan-Meier analysis and adherence between groups was compared using a 2-sided log-rank test (Mantel-Cox). Cases where termination of ET was due to progressive disease or death were censored. Statistical significance was set at P values less than .05. Mean value ± standard error of the mean (SEM) is given in the text or median (95% confidence interval) where indicated. IBM SPSS Statistics version 26 (IBM Corp, Armonk, NY, USA) and GraphPad Prism program 9.1.0 (GraphPad Software, Inc, San Diego, CA, USA) were used to analyse data.
+ Open protocol
+ Expand
2

Survival Analysis of Targeted Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chi-square test was performed to compare categorical variables, and the Mann–Whitney U test was performed to compare continuous variables between the groups. Cox regression univariate and multivariate analyses were performed to identify factors predicting overall survival, and crude hazard ratios (CHRs) and adjusted hazard ratios (AHRs) with 95% confidence intervals (CIs) were estimated. Targeted therapy constituted a time-dependent variable in the Cox regression analyses. p-Values less than 0.05 were considered statistically significant. The mean value ± standard deviation (SD) is given in the text. Our statistical consultant, author U.S., controlled the statistics in the study. IBM SPSS Statistics version 26 (IBM Corp., Armonk, NY, USA) and GraphPad Prism program 9.1.0 (GraphPad Software, Inc., San Diego, CA, USA) were used to analyze the data.
+ Open protocol
+ Expand
3

Prognostic Role of PrP^C in HCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
To avoid confusion of analysis and focus on the role of PrPC as a prognostic factor in HCC recurrence and overall survival, we applied the following standards in this study. First, we considered only when HCC recurrence was observed according to radiologic evidence. Second, only deaths from hepatic origin were considered for overall survival. We did not analyze non-hepatic origin deaths in determining cumulative survival rates. Based on the same criteria, multivariate analyses for recurrence and survival were performed using the Cox regression hazard model or logistic regression model.
Data are expressed as the mean ± SD or median (range). For statistical significance, Student’s t-test and χ2 test were conducted for comparisons of variables between groups. The cumulative recurrence and survival were evaluated by the Kaplan–Meier method, and differences were determined by the log rank test. A multivariate analysis was carried out to identify independent predictors for recurrence and survival using a Cox regression hazard model or logistic regression model. A value of p < 0.05 was regarded as significant. All analyses were performed using SPSS 27.0 software (SPSS, Inc., Chicago, IL, USA) and GraphPad Prism 9 program (GraphPad software, San Diego, CA, USA).
+ Open protocol
+ Expand
4

Enzymatic Hydrolysis Optimization for Biofuel Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
All results were performed as mean with SD by Microsoft 365 Excel 2012. Moreover, these results were examined statistically through one-way ANOVA with SPSS statistical software (version 19.0). Duncan’s multiple range test evaluated the significance of the difference between groups based on a confidence level of 95.0%. Enzymatic hydrolysis condition was analyzed using Design-Expert program version 11 from Stat-Ease, Inc., Minneapolis, United States. The IC50 values were performed with the GraphPad PRISM 9 program (GraphPad Software, Inc., San Diego, CA, United States).
+ Open protocol
+ Expand
5

Assessing Tumor Spheroid Response to Combination Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
The endocrine/solid tumor cell lines 22Rv1, LNCaP, MDA PCa 2b, HT-29, A549 and MCF-7 were seeded at densities of 500-2,000 cells/well in the 96-well Nunclon Sphera-treated plates (catalog# 174925, Thermo Fisher Scientific, Waltham, MA, USA) containing DMEM/10% FBS media. The tumor spheroids were first incubated at 37°C in a 5% CO2 incubator for 2 days, then 25 μM of Idelalisib, 25 μM of SRPIN340, or a combination of Idelalisib (25 μM) and SRPIN340 (25 μM) were added as treatments for additional 5 days. For monitoring the spheroid growths, each well was imaged every day using Olympus IX73 microscope (Olympus, Bartlett, TN, USA) and then the spheroid diameter, area and circularity were measured by ImageJ. For measuring the cell viabilities of spheroids under different drug treatments, the CellTiter 96 Non-Radioactive Cell Proliferation Assay reagent (Promega, Madison, WI, USA) was added to each well and incubated with the spheroids for 3 h at 37°C, then the solubilization solution was added. After incubation for 1h, the samples were detected by the Multiskan FC microplate photometer (Thermos Fisher Scientific, Waltham, MA, USA) at the wavelength of 570 nm. The data were analyzed by GraphPad Prism 9 program (GraphPad, La Jolla, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!